Market Overview

Positive Results from Phase III Study Evaluating Oral OTEZLA (Apremilast) or Injectable Etanercept versus Placebo in Patients with Plaque Psoriasis Presented at AAD

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA

 

Related Articles (CELG)